The following information is provided to satisfy virtual marking requirements of various jurisdictions including Section 287(a) of Title 35 of the United States Code and to provide notice of patent rights of Astrea UK Services Limited.
Astrea Bioseparations products are covered by or for use under one or more of the following U.S. patents and other country patents. Other patents pending.
|EtoxiClear®||EP 1,507,563; US 8,765,393|
|Evolve®||Patent Pending PCT application PCT/GB2023/051209|
|HCPure™||Patent Pending UK application 2218303.2|
|Nanofiber membrane separation technology and devices, including Nereus®||EP 2,959,509; US 9,604,168; US 10,293,289; US 10,919,986; US 11,466,386; US11,506,438|
|Purabead®||Patent Pending UK application 2113284|
|SNAP®||US 7,901,574; US 8,318,010|
Last updated: 9 May 2023